PsyAccess
Spravato®Registry-verifiedDesignated-centers model

Uniwersytecki Szpital Kliniczny Nr 1 W Lublinie

Lublin, Poland

Treatment & access

About this provider

University Clinical Hospital No. 1 in Lublin (Uniwersytecki Szpital Kliniczny nr 1 w Lublinie) is the teaching hospital of the Medical University of Lublin. Per NFZ data it runs the fully funded NFZ esketamine program B.147 for treatment-resistant depression. Per its own site, its II Psychiatry and Psychiatric Rehabilitation Clinic at ul. Głuska 1 has a 41-bed general psychiatric ward with dedicated mood-disorder and psychotic-disorder units, offers psychiatric and psychological diagnostics, pharmacotherapy, psychotherapy and occupational therapy, and performs electroconvulsive therapy for treatment-resistant depression.

Services & programs

  • II Psychiatry and Psychiatric Rehabilitation Clinic, ul. Głuska 1 — general psychiatric ward (41 beds)
  • Mood Disorders Treatment Unit (21 beds) and Psychotic Disorders Treatment Unit (20 beds)
  • Electroconvulsive therapy under short general anaesthesia, including for treatment-resistant depression
  • Psychiatric and psychological diagnostics: laboratory, neuroimaging, neurophysiological and neuropsychological testing
  • Pharmacotherapy, psychotherapy, psychoeducation, occupational therapy (culinary training, art therapy, bibliotherapy)
  • I Psychiatry, Psychotherapy and Early Intervention Clinic with day units
  • Care available for English-speaking patients
  • NFZ drug program B.147 — esketamine for treatment-resistant depression (per NFZ data)

Common questions

How does admission for the esketamine program work in Lublin?

You need a valid referral from a psychiatrist. Patients with a referral report to the Psychiatric Clinics admissions unit (Izba Przyjęć Klinik Psychiatrii) at ul. Głuska 1, where the duty physician decides on qualification. B.147 criteria apply: age 18-75, treatment-resistant depression after at least two adequate antidepressant trials.

Do I pay for the treatment?

No. Program B.147 is fully NFZ-funded — esketamine (Spravato), its administration and observation are free of charge for up to 34 weeks.

What is the waiting situation?

Per NFZ data (as of June 2026), the first available date was 2026-07-01 with no queue. The clinic secretariat (81 744 09 67, weekdays 7:30-15:05) can confirm current availability.

Looking at alternatives? One of the NFZ program B.147 centers — see all program centers in Poland in the directory and the Poland access guide.

Verification

This record was taken directly from an official registry or program list and is re-checked on a rolling cadence.

Spotted an error? See our methodology for how records are checked and how to report a correction.